Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage ...

Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data from ...

Agnico Eagle Mines Limited (AEM) Presents at Emerging Growth Conference 88 Transcript

Emerging Growth Conference 88 December 11, 2025 9:05 AM ESTCompany ParticipantsJean-Marie Clouet - Vice President ...

Q2 Metals Announces Results of AGM and Year-End Webcast

Q2 Metals will host a live year-end webcast presentation on Thursday, December 18 at 08:00 AM PST (11:00 AM EST). Management will review the Company’s 2025 performance, highlight upcoming catalysts, ...
MyHorryNews

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ...

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price

Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...